We are live on ! Find out more
HFCIV

H&F Corporate Investors VIII Portfolio holdings

AUM $133M
1-Year Est. Return 24.42%
This Fund
S&P 500
This Quarter Est. Return
-14.4%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
AUM
$3.63B
AUM Growth
Cap. Flow
+$3.74B
Cap. Flow %
103.06%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PPD
PPD, Inc. Common Stock
PPD
+$1.95B
2
CTEV
Claritev Corp
CTEV
+$1.79B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPD
1
DELISTED
PPD, Inc. Common Stock
PPD
$1.91B 52.55%
+55,722,731
New +$1.95B
CTEV
2
Claritev Corp
CTEV
$652M
$1.72B 47.45%
+5,387,862
New +$1.79B

Similar funds

H&F Corporate Investors VIII's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for H&F Corporate Investors VIII, which disclosed 2 positions worth $3.63B. Its ten largest holdings account for 100% of the portfolio.

Its largest position is PPD, Inc. Common Stock: 55,722,731 shares worth $1.91B.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • H&F Corporate Investors VIII's largest Q4 2020 buy was PPD, Inc. Common Stock: 55,722,731 shares worth $1.91B.
  • H&F Corporate Investors VIII's ten largest holdings make up 100% of its $3.63B portfolio in Q4 2020.
  • H&F Corporate Investors VIII disclosed 2 positions in Q4 2020, its first 13F filing on record.

Based on H&F Corporate Investors VIII's 13F filing for Q4 2020, filed 16 Feb 2021.